e-learning
resources
Barcelona 2010
Wednesday, 22.09.2010
Novel cellular mechanisms in lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Role of influenza virus infection in lung fibrosis
A. Baccioglu Kavut, K. J. Staples, L. C. Lau, R. Djukanovic, B. Nicholas (Kirikkale, Turkey; Southampton, United Kingdom)
Source:
Annual Congress 2010 - Novel cellular mechanisms in lung disease
Session:
Novel cellular mechanisms in lung disease
Session type:
E-Communication Session
Number:
5693
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Baccioglu Kavut, K. J. Staples, L. C. Lau, R. Djukanovic, B. Nicholas (Kirikkale, Turkey; Southampton, United Kingdom). Role of influenza virus infection in lung fibrosis. Eur Respir J 2010; 36: Suppl. 54, 5693
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Effusions related to TB
Laboratory diagnosis of tuberculosis
Related content which might interest you:
Respiratory viral agents in cystic fibrosis
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005
Emergence of an immunosuppressive neutrophil phenotype during pneumococcal lung co-infection with influenza A virus
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Frequency and characteristics of prolonged viral shedding of influenza A/H1N1 virus in lung transplant recipients
Source: Annual Congress 2011 - Lung transplantation
Year: 2011
Clarithromycin inhibits pandemic A/H1N1/2009 influenza virus infection in human airway epithelial cells
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012
Assessment of viral load and time course of pulmonary inflammation in a murine model of H1N1 (PR8) influenza virus infection
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
Severe influenza virus H1N1: Lung pathology
Source: Annual Congress 2010 - Influenza A (H1N1): epidemiology
Year: 2010
Cytokine response in pediatric patients with pandemic H1N1 influenza virus infection and pneumonia: Comparison with pediatric pneumonia without H1N1 infection
Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection
Year: 2011
Influenza and co-infections of the lung
Source: International Congress 2014 – ERS/Lancet and Lancet Respiratory Medicine joint session: complicating infections in respiratory disease and critical care
Year: 2014
The role of viruses in chronic bronchitis and exacerbations of COPD
Source: Eur Respir Monogr 2013; 60: 68-75
Year: 2013
The role of epithelial-mesenchymal transition in the possibility of chronic process in the lungs during influenza pneumonia, caused by the virus AH1N1
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012
The role of hepatitis C virus infections in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 333s
Year: 2005
Epidemic and pandemic viral infections: impact on tuberculosis and the lung
Source: Eur Respir J, 56 (4) 2001727; 10.1183/13993003.01727-2020
Year: 2020
Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma
Source: Eur Respir J 2002; 19: 68-75
Year: 2002
Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection
Source: Eur Respir Rev, 30 (162) 210194; 10.1183/16000617.0194-2021
Year: 2021
The immunology of virus infection in asthma
Source: Eur Respir J 2001; 18: 1013-1025
Year: 2001
Influenza vaccine-induced interstitial lung disease
Source: Eur Respir J 2013; 41: 474-477
Year: 2013
Epstein-Barr virus specific antibodies in patients with idiopathic pulmonary fibrosis and presence of EBV in respiratory tract: reactivation of infection?
Source: Eur Respir J 2005; 26: Suppl. 49, 333s
Year: 2005
Respiratory syncytial virus in adults: relationships between viral load, symptoms and lung function in an experimental infection model
Source: Annual Congress 2008 - New diagnostic methods in viral and atypical infections
Year: 2008
Acutely lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016
Decreased lung function precedes severe respiratory syncytial virus infection and post-respiratory syncytial virus wheeze in term infants
Source: Eur Respir J 2014; 44: 666-674
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept